A classification model for BRCA2 DNA binding domain missense variants based on homology-directed repair activity
about
PALB2: research reaching to clinical outcomes for women with breast cancerBeyond DNA: An Integrated and Functional Approach for Classifying Germline Variants in Breast Cancer GenesMolding BRCA2 function through its interacting partnersClinical and molecular characterization of the BRCA2 p.Asn3124Ile variant reveals substantial evidence for pathogenic significance.Functional and mutational landscapes of BRCA1 for homology-directed repair and therapy resistanceTwo decades after BRCA: setting paradigms in personalized cancer care and preventionInherited mutations in 17 breast cancer susceptibility genes among a large triple-negative breast cancer cohort unselected for family history of breast cancer.Germline variation in cancer-susceptibility genes in a healthy, ancestrally diverse cohort: implications for individual genome sequencing.A targeted analysis identifies a high frequency of BRCA1 and BRCA2 mutation carriers in women with ovarian cancer from a founder population.Germline TP53 mutational spectrum in French Canadians with breast cancer.Double PALB2 and BRCA1/BRCA2 mutation carriers are rare in breast cancer and breast-ovarian cancer syndrome families from the French Canadian founder populationTowards Increasing the Clinical Relevance of In Silico Methods to Predict Pathogenic Missense VariantsFunctional Assessment of Genetic Variants with Outcomes Adapted to Clinical Decision-MakingCharacterization of BRCA1 and BRCA2 variants in multi-ethnic Asian cohort from a Malaysian case-control studyFunctional classification of DNA variants by hybrid minigenes: Identification of 30 spliceogenic variants of BRCA2 exons 17 and 18.Recurrent mutations of BRCA1, BRCA2 and PALB2 in the population of breast and ovarian cancer patients in Southern PolandBRCA1/2 sequence variants of uncertain significance: a primer for providers to assist in discussions and in medical management.BRCA2 Polymorphic Stop Codon K3326X and the Risk of Breast, Prostate, and Ovarian CancersTargeted sequencing of BRCA1 and BRCA2 across a large unselected breast cancer cohort suggests that one-third of mutations are somaticBRCA1 and BRCA2 genetic testing-pitfalls and recommendations for managing variants of uncertain clinical significance.Genomic Biomarkers for Breast Cancer Risk.Multifactorial likelihood assessment of BRCA1 and BRCA2 missense variants confirms that BRCA1:c.122A>G(p.His41Arg) is a pathogenic mutation.Functional assays for analysis of variants of uncertain significance in BRCA2.Analysis of chromosomal radiosensitivity of healthy BRCA2 mutation carriers and non-carriers in BRCA families with the G2 micronucleus assayBRCA2 Hypomorphic Missense Variants Confer Moderate Risks of Breast Cancer.Hereditary breast and ovarian cancer: new genes in confined pathways.Association of the germline BRCA2 missense variation Glu2663Lys with high sensitivity to trabectedin-based treatment in soft tissue sarcoma.Characterization of BRCA1 and BRCA2 variants found in a Norwegian breast or ovarian cancer cohort.BRCA1 and BRCA2 germline variants in breast cancer patients from the Republic of Macedonia.Assessment of the Clinical Relevance of BRCA2 Missense Variants by Functional and Computational Approaches.Development and validation of a new algorithm for the reclassification of genetic variants identified in the BRCA1 and BRCA2 genes.Capillary electrophoresis analysis of conventional splicing assays: IARC analytical and clinical classification of 31 BRCA2 genetic variants.Performance of in silico prediction tools for the classification of rare BRCA1/2 missense variants in clinical diagnostics.
P2860
Q26751309-059DD925-A6DB-404C-A439-73037527CBD3Q28072478-41E50776-9E64-4DD8-8351-EFAE4814E576Q28085603-67B66A25-F63C-4DDB-9966-FEE48CCFF14FQ30361333-20B0F0E4-86B0-4CB1-B65A-74127217AA48Q33688407-E0A9C9EF-BA60-41B5-9ED7-63DF6F25EE07Q33820594-BAC19DC7-BF09-456C-884C-4358B8A7D2ADQ34996647-B294A898-A089-4B10-903C-0022ED97DE7DQ35146870-21F8D4F8-32EE-4A76-899C-2EB3E9B5E09CQ35223166-598C7290-2245-482C-964E-14A8E4A4FEA7Q35618321-7476DA1B-EAF9-49AC-935B-E875C47E48A9Q35758939-25A5A1E0-F400-42A3-A322-716B3722FAF7Q36015435-07F2D08D-89B2-4A35-B8C9-55F7DDDFC72BQ36044085-B9DBFB65-D5BD-4C12-A9F3-C8F14E4E3B1DQ36286700-EE508C29-6926-4836-886D-A58A3C452EF2Q36322003-28BD2E1D-7EE6-4AA7-AFE8-2A3E3BA3BFDDQ36538025-F316BD41-9526-4D4B-A2BA-FB301AE32A39Q36871668-4955C149-9699-4A14-A826-F57B518368CDQ37002955-E9182E09-9A67-4BE8-93BE-A00D08464D09Q37123931-1C2641F4-4A75-414A-A53A-C3D14E39DDBBQ37220433-254EAB4A-1E8A-43D9-8B78-9FBAC4D8E1AAQ37242239-CA132D14-9221-4211-AE2E-D900151EA3E7Q37525477-94DE95D1-29BE-4FEB-8D3E-7359E9002CF8Q37715826-0E57AA01-C422-48E5-ACE0-1608570FAC44Q37720025-87DCBF49-E38A-4925-BB9C-4D7C0F735A31Q38914005-C3803D96-6168-4148-A16F-20B0EC260D2FQ38925408-77A0BA9D-7EDD-4194-8808-CA4422D9A25AQ39454037-A551FC55-BEDB-4888-B154-9E2063847594Q48124777-F4D1ADEB-339F-40BB-8E73-6CEE98353F92Q48238594-3764C03C-6A19-40CA-9735-FB8F86BD234CQ50210067-1C677E51-04E5-4E9B-BB0E-554690F015D3Q51062318-5766B007-856A-4C8A-877F-4A1B01B245CCQ53101648-D11745EC-A9A3-466A-B937-4E1BF66BE2D3Q55186226-8B0D4A78-4E62-4189-AAA5-81234593307B
P2860
A classification model for BRCA2 DNA binding domain missense variants based on homology-directed repair activity
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
A classification model for BRC ...... ology-directed repair activity
@ast
A classification model for BRC ...... ology-directed repair activity
@en
type
label
A classification model for BRC ...... ology-directed repair activity
@ast
A classification model for BRC ...... ology-directed repair activity
@en
prefLabel
A classification model for BRC ...... ology-directed repair activity
@ast
A classification model for BRC ...... ology-directed repair activity
@en
P2093
P2860
P50
P1433
P1476
A classification model for BRC ...... ology-directed repair activity
@en
P2093
Catherine A Erding
Christian Singer
David E Goldgar
James Thompson
Lucia Guidugli
Namit Singh
Noralane M Lindor
Patricia N Tonin
Vernon S Pankratz
P2860
P304
P356
10.1158/0008-5472.CAN-12-2081
P407
P577
2012-10-29T00:00:00Z